Execution CopyLicense Agreement • May 28th, 2019 • Genmab a/S • Pharmaceutical preparations
Contract Type FiledMay 28th, 2019 Company Industry[***] Certain information in this document, marked by brackets, has been excluded pursuant to Item 601(b)(10)(iv) of Regulation S-K under the Securities Act of 1933, as amended, because it is both (i) not material and (ii) would likely cause competitive harm to the registrant if publicly disclosed.
Execution CopyLicense Agreement • April 2nd, 2019 • Genmab a/S • Pharmaceutical preparations
Contract Type FiledApril 2nd, 2019 Company Industry[***] Certain information in this document, marked by brackets, has been excluded pursuant to Item 601(b)(10)(iv) of Regulation S-K under the Securities Act of 1933, as amended, because it is both (i) not material and (ii) would likely cause competitive harm to the registrant if publicly disclosed.